News Agency
Men's Weekly

Boan Biotech's Two Innovative Drugs Targeting Claudin 18.2 Granted ODD by FDA

  • Written by PR Newswire

YANTAI, China, Dec. 27, 2023 /PRNewswire/ -- Boan Biotech today announced that two of its Claudin18.2-targeted investigational drugs have been granted the Orphan Drug Designation (ODD) for the treatment of pancreatic cancer by the U.S. Food and Drug Administration (FDA): one is BA1105, an innovative antibody; and the other is BA1301, an innovative...

Read more: Boan Biotech's Two Innovative Drugs Targeting Claudin 18.2 Granted ODD by FDA

The Power of Creative Agencies in Shaping Modern Brands

In today’s digital era, businesses are constantly seeking innovative ways to connect with their audiences and stand out in a crowded marketplace. Creative agencies have emerged as key partners in achieving these goals. By combining design, strategy, content creation, and... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion